News

Patients with a neutrophil-to-lymphocyte ratio (NLR) above 4.8 had significantly worse clinical outcomes. Elevated NLR was ...
Recent ASCO 2025 findings reveal new insights into melanoma treatment, highlighting challenges and advancements in adjuvant ...
DelveInsight’s Refractory Metastatic Melanoma pipeline report depicts a robust space with 4+ active players working to ...
Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...
Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...
When Katie Doble was diagnosed with a rare cancer, she was given 16 months to live. Clinical trials gave her a second chance.